News

24.10.2024

EMSP at ECTRIMS 2024 – Key takeaways

EMSP delegates actively participated in the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis ECTRIMS…

ΠουΣ App: Empowering MS Patients for Better Symptom Management

23.10.2024

Managing symptoms of Multiple Sclerosis (MS) can significantly enhance patients’ quality of life. These symptoms may include fatigue, muscle weakness,…

Assisi Hosts First G7 Summit on Inclusion and Disability

23.10.2024

On 14th October, the historic town of Assisi, Italy—birthplace of Saint Francis—hosted the inaugural G7 Summit focused on Inclusion and…

23.10.2024

Celebrating Strength and Resilience: 7th Annual Roskiáda in Nymburk

From 13th to 15th September 2024, the 7th annual Roskiáda, a sports event for people living with multiple sclerosis, took…

New Study Confims the Validity of an App for MS Cognitive Assessment

23.07.2024

The evaluation of cognitive impairments for people affected by Multiple Sclerosis – such as memory, information processing speed, and attention- …

Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design

12.07.2024

On June 19, 2024, the Multiple Sclerosis Community Advisory Board (MS CAB) met with the EBV-MS project research team for…

09.07.2024

Preliminary Results of the Impact of Multiple Sclerosis Symptoms (IMSS) Survey Presented at RIMS Annual Conference

The 29th annual RIMS Conference held between 27 and 29 June 2024, marked a significant milestone for the MS community…

Changes on EMSP Executive Committee

21.05.2024

We are thrilled to announce some exciting updates on the EMSP Executive Committee, including the appointment of a new Treasurer…

MEPs from across EU endorsing EMSP Manifesto

21.05.2024

During the EMSP conference in April, attendees had an early glimpse of videos from MEPs supporting our European Elections 2024…

1 2 3 11